Gliclazide

Gliclazide

Product Name Gliclazide
CAS Number 21187-98-4
Molecular Formula C15H21N3O3S
Molecular Weight 323.41 g/mol
Appearance White or almost white crystalline powder
Assay (HPLC) 98.0% - 102.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 10 ppm
Melting Point 163°C - 169°C
Specific Rotation Not applicable (racemic mixture)

Need help? Contact our team

Gliclazide Structure

Synonyms

  • Gliclazide, Diamicron, Glimicron, Diabezide, Glizide, Glyclazide, 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-(4-methylphenylsulfonyl)urea

Gliclazide has been a cornerstone in type 2 diabetes management for decades, and it’s still widely prescribed today — because it works. As a second-generation sulfonylurea, it stimulates insulin release from pancreatic beta cells, helping patients lower blood glucose without the extreme peaks and troughs seen with some older agents. What sets gliclazide apart is its unique azabicyclo-octyl ring, which gives it a favorable safety profile, particularly for cardiovascular outcomes. That’s why it remains a trusted choice in many national formularies, especially in Europe and Asia.

For manufacturers and formulators, gliclazide offers a reliable, well-documented API with predictable pharmacokinetics and a proven track record. We supply gliclazide as a high-purity crystalline powder, every batch meeting strict pharmacopoeial standards and shipped with a full COA. Whether you need a 1 kg sample for R&D or a full container load for commercial production, we’ve got the flexibility and logistics to keep your supply chain moving.

Function

  • Insulin secretagogue: Binds to sulfonylurea receptors on pancreatic beta cells, closing ATP-sensitive potassium channels and triggering calcium influx — leading to rapid, glucose-dependent insulin release.
  • Glycemic control: Effectively lowers HbA1c levels, with a once-daily dosing regimen that improves patient compliance compared to multiple-dose sulfonylureas.
  • Cardiovascular safety: Gliclazide has been shown to have neutral or beneficial effects on the cardiovascular system, unlike some older sulfonylureas; it also reduces oxidative stress and platelet aggregation, adding a layer of protection for diabetic patients.

Documentation & Supply

  • Documentation: COA, MSDS, TDS
  • Lead time: 5-10 days for standard orders, with expedited options available
  • Packaging: Double-layer polyethylene bags inside fiber drums, 25 kg per drum, or custom packing per request

Request For Quote

  • Our Address: 280 Main Street, Xian, Shaanxi, China
  • LyvBio Co., Ltd. — Email: info@lyvbio.com

STAY IN TOUCH

Request For Quote

Our Address

Room,5-0203, Courtyard 205, Lianhu District,Xi'an,Shaanxi,China

×